+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05346536

Study of AXL-Positive Circulating Tumor Cells Detection Using EPIDROP and CellSearch in Metastatic Pancreatic Cancer

Led by University Hospital, Montpellier · Updated on 2026-06-22

63

Participants Needed

1

Research Sites

119 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating pancreatic adenocarcinoma and metastatic breast cancer, focusing on circulating tumor cells CTCs that detach from primary tumors and spread to other organs. These CTCs, when expressing the AXL protein, are linked to tumor growth, survival, and drug resistance. The study aims to compare two methods for detecting AXL-expressing CTCs using liquid biopsy, a non-invasive blood test, to improve understanding of tumor progression and treatment monitoring. Participants will have their blood tested using two techniques the FDA-approved CellSearch system and the innovative EPIDROP method. Both methods isolate and analyze CTCs expressing AXL to assess concordance and accuracy. The study also explores immune system markers and the potential to create a biobank of plasma samples. The goal is to better characterize CTCs and their role in pancreatic cancer prognosis and therapy. Throughout the trial, participants will undergo blood sampling and immune analysis at inclusion. Researchers will measure the concordance of CTC-AXL detection between methods and evaluate overall survival and progression-free survival over 36 months. Additional assessments include immune cell evaluations and PD-L1 expression on CTCs. This detailed monitoring helps understand the relationship between CTCs, immune response, and clinical outcomes in metastatic pancreatic cancer.

CONDITIONS

Brief Title

Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC)

Research Team

T

Thomas Bardol, MD

S

Sarah Girot

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here